Sinovac Announces Product License for 23-Valent Pneumococcal Polysaccharide Vaccine

Source :: Business Wire. December 9, 2020
Publication Year :: 2020
Abstract: BEIJING -- Sinovac Biotech Ltd. (NASDAQ:SVA) ('Sinovac' or the 'Company'), a leading provider of biopharmaceutical products in China, today announced that the China National Medical Products Administration (NMPA) has approved [...]

Subjects :: Sinovac Biotech Ltd. -- Product introduction
Vaccines -- Product introduction
Polysaccharides -- Product introduction
Pneumonia
Biological products industry -- Product introduction
Business
Business, international

Tools